[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Centervue SpA\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":86},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,37,61],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":4},"100624055","preliminary-assessment-of-an-automated-tool-for-diabetic-retinopathy-screening-100624055",false,"NCT07404657","Preliminary Assessment of an Automated Tool for Diabetic Retinopathy Screening","Preliminary Assessment of iCare RETCAD as an Automated Tool for Diabetic Retinopathy Screening","Inclusion Criteria:\n\n* 22 years old or older\n* diabetes or diabetic retinopathy\n* understand the study information and able to sign a consent form\n\nExclusion Criteria:\n\n* cannot tolerate eye imaging tests\n* laser treatment or injections\n* eye surgery, except for simple cataract surgery\n* currently involved in another study\n* pregnant\n* cannot or do not want to have your eyes dilated\n* photodynamic therapy within the last 90 days","ALL","22 Years",{"count":19,"type":20},198,"ESTIMATED","OBSERVATIONAL","This study is being done to evaluate the performance of a software that uses artificial intelligence to analyze photographs of the retina to help detect diabetic retinopathy. The study will also assess the safety of the software in combination with a fundus camera already available on the market. This software analyzes retinal photographs to detect more than mild diabetic retinopathy in adults with diabetes. The results will be compared to expert human evaluations.",[24],"Diabetic Retinopathy (DR)","NOT_YET_RECRUITING","2026-02-05",{"date":28,"type":29},"2026-02-11","ACTUAL",{"date":31,"type":20},"2026-02",{"date":33,"type":20},"2026-04",{"name":35,"class":36},"Centervue SpA","INDUSTRY",{"id":38,"slug":39,"hasResults":11,"nctId":40,"briefTitle":41,"officialTitle":42,"acronym":4,"eligibilityCriteria":43,"healthyVolunteers":11,"sex":16,"minAge":44,"maxAge":45,"enrollmentInfo":46,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":48,"conditions":49,"keywords":4,"overallStatus":51,"whyStopped":4,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":55,"completionDateStruct":57,"leadSponsor":59,"locationsCount":60},"100500839","clinical-evaluation-of-visual-field-change-in-glaucoma-an-assessment-of-different-models-of-progression-100500839","NCT05801471","Clinical Evaluation of Visual Field Change in Glaucoma: an Assessment of Different Models of Progression","An Observational Prospective Longitudinal Study for the Clinical Evaluation of Visual Field Change in Glaucoma. An Assessment of Different Models of Progression","Inclusion Criteria:\n\n* Glaucomatous optic nerve head in both eyes;\n* Age between 40 and 90 years;\n* Best Corrected Visual Acuity ≤ 0.3 \\[logMar\\];\n* Spherical refraction between -6D and +6D;\n* Astigmatism between -2D and +2D.\n\nExclusion Criteria:\n\n* Any ocular surgery, except for: uncomplicated cataract surgery and\u002For glaucoma surgery in both eyes performed within 6 months before enrollment;\n* Any ocular pathology that can affect visual field other than glaucoma;\n* Use of any drug that can interfere with the correct execution of perimetry or that would produce visual field loss;\n* Inability to obtain reliable perimetric examinations;\n* Patients with advanced glaucoma for whom, according to the clinician, a 24-2 grid is not advisable to correctly monitor the patient.","40 Years","90 Years",{"count":47,"type":20},200,"The purpose of this observational study is to collect over time a series of data in patients with glaucoma in order to evaluate different approaches in defining the progression of this pathology. These data will be collected in repeated visits over a 36-months follow-up period. At each visit, the COMPASS fundus perimeter and the Humphrey Field Analyzer (HFA) perimeter will be used to assess retinal functionality; an Optical Coherence Tomography (OCT) examination will also be performed to evaluate and obtain clinical information about the structure of the retina.",[50],"Glaucoma","RECRUITING","2025-12-29",{"date":54,"type":29},"2026-01-02",{"date":56,"type":29},"2022-05-06",{"date":58,"type":20},"2028-11-06",{"name":35,"class":36},2,{"id":62,"slug":63,"hasResults":11,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":4,"eligibilityCriteria":67,"healthyVolunteers":68,"sex":16,"minAge":69,"maxAge":4,"enrollmentInfo":70,"targetDuration":4,"studyType":72,"phases":73,"briefSummary":75,"conditions":76,"keywords":4,"overallStatus":51,"whyStopped":4,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":5},"100592261","clinical-investigation-of-maia-microperimeter-device-mesopic-normative-database-collection-100592261","NCT06991127","Clinical Investigation of MAIA Microperimeter Device: Mesopic Normative Database Collection","Pre-market Multicentric Cross-sectional Clinical Investigation of MAIA Microperimeter Device: Mesopic Normative Database Collection","Inclusion Criteria:\n\n* Age: ≥18 years old;\n* Best Corrected Visual Acuity (BCVA): ≥ 0.8 Decimal (≥ 20\u002F25 ft, ≤ +0.1 logMAR) at least in the study eye;\n* Equivalent spherical refraction between the range ≥ -6D and ≤ +6D; astigmatism within 2D (≤ 2D) at least in the study eye;\n* Intraocular Pressure (IOP) ≤ 21 mmHg in both eyes (Goldmann applanation tonometer);\n* Clinically normal appearance of the optic nerve head according to clinical judgement (no evidence of excavation, rim thinning, notching, disc hemorrhages, RNFL thinning) in both eyes. This is examined with Spectralis or Solix OCT;\n* Clinically normal appearance of the macula according to clinical judgement, in both eyes. This is examined with Spectralis or Solix OCT;\n* No ocular pathologies, trauma, surgeries (apart from uncomplicated cataract surgery or peripheral laser retinopexy performed at least 6 months before enrollment) in both eyes;\n* Absence of pathologies that can affect visual field in both eyes;\n* No use of drugs interfering with the correct execution of perimetry.\n\nExclusion Criteria:\n\n* Glaucoma or glaucoma suspect diagnosis in either eye;\n* Presence or history of ocular hypertension (IOP ≥ 22 mmHg) in either eye;\n* Presence or history of disc hemorrhage in either eye;\n* Presence of amblyopia in either eye;\n* Nystagmus or poor fixation in either eye;\n* Previous laser or any ocular surgery, including uncomplicated cataract surgery performed within 6 months before enrollment in both eyes;\n* Any active infection of anterior or posterior segments in the study eye;\n* Subjects with significant ocular media opacities preventing acquisition of acceptable infrared (IR) fundus image quality in the study eye;\n* Evidence of diabetic retinopathy, diabetic macular edema, or other retinal disease in either eye;\n* Use of any drug that can interfere with the correct execution of MP or that would produce visual field loss;\n* Unable to tolerate ophthalmic imaging;\n* Claustrophobia;\n* Inability to provide informed consent.",true,"18 Years",{"count":71,"type":20},380,"INTERVENTIONAL",[74],"NA","The purpose of this pre-market, multicentric cross-sectional study is to create a mesopic Normative Database for a new version of the MAIA device. Moreover, the study aims to evaluate MAIA safety and adverse events. These purposes will be achieved by collecting data of healthy subjects, who will undergo microperimetric examinations with the MAIA device during one single visit.",[77],"Healthy Eyes","2025-05-19",{"date":80,"type":29},"2025-05-25",{"date":82,"type":29},"2025-04-23",{"date":84,"type":20},"2026-06-01",{"name":35,"class":36},""]